Fmoc-L-propargylglycine

CAS: 198561-07-8

Ref. 3D-FF40126

Información del producto

• Nombre: Fmoc-L-propargylglycine
• Sinónimos: (2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-ynoic acid, (2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)pent-4-ynoic acid, (2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-pentynoic acid, (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-ynoic acid, (S)-2-(Fmoc-Amino)-4-Pentynoic Acid, 4-Pentynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-, 4-Pentynoic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (S)-, Fmoc-(S)-2-Propargylglycine, Fmoc-<span class="text-smallcaps">L</span>-propargylglycine, Fmoc-Pra-Oh, N-Alpha-(9-Fluorenylmethoxycarbonyl)-(S)-2-Amino-4-Pentynoic Acid, N-Alpha-(9-Fluorenylmethoxycarbonyl)-Propargylglycine, N-Alpha-(9-Fluorenylmethyloxycarbonyl)-L-Propargylglycine, Rarechem Bk Pt 0257
• CAS: 198561-07-8

Descripción

Fmoc-L-propargylglycine is a cyclic peptide that is synthesized by chemical ligation. It has antiviral, anti-tumor, and anti-inflammatory activities. Fmoc-L-propargylglycine inhibits the growth of cancer cells in vitro. The mechanism of action is not fully understood, but it may involve the inhibition of cellular proliferation and the induction of apoptosis. This compound also inhibits epidermal growth factor (EGF) induced cell proliferation in caco-2 cells.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 335.35 g/mol
• Fórmula: C₂₀H₁₇NO₄
• Pureza: Min. 98 Area-%
• Color/Forma: White Powder
• InChI: InChI=1S/CH4/h1H4
• Clave InChI: InChIKey=VNWKTOKETHGBQD-UHFFFAOYSA-N
• SMILES: C#CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O